Medical Principles and Practice 2023, Vol. 32, No. 2
The Role of Intermittent Fasting and Dieting on Cognition in Adult Population: A Systematic Review of the Randomized Controlled Trials
Dietary approaches such as low-glycemic diets and caloric restriction have shown improvements in cognitive function.
Dietary approaches may have a negative impact on problem-solving in those with comorbid cardiovascular disease.
There is contradictory evidence that caloric restriction and diet alone is sufficient for the improvement of the cognitive functions.
Subjective and Objective Assessment of Chewing Performance in Older Adults with Different Dental Occlusion
The New Coronavirus Pandemic and the Trend of Breast Cancer Diagnosis according to Age-Group: Total and Interrupted Time Series Study
The recent COVID-19 pandemic has changed the stationary trend to a decreasing trend of mammograms in all age-groups.
The pandemic has reversed the increasing trend of breast biopsies and breast cancer diagnosed at stages 0 to II.
The pandemic has not influenced the increasing trend of breast cancer diagnosed at stages III and IV.
Antibiotic Sensitivity of Group B Streptococcus from Pregnant Mothers and Its Association with Resistance Genes
Penicillin remains the drug of choice for group B Streptococcus in Sri Lanka.
An increase in resistance to erythromycin and clindamycin with inducible clindamycin resistance was seen for group B Streptococcus.
ermTR is the predominant resistance gene responsible for erythromycin and clindamycin resistance, and it is significantly associated with inducible clindamycin resistance phenotype.
Diagnostic and Prognostic Performance of Plasma Albumin and Cholinesterase in Patients with Sepsis and Septic Shock
Data regarding the prognostic role of plasma albumin and cholinesterase in the sepsis-3 era is limited.
In 239 patients with sepsis and septic shock, cholinesterase was associated with moderate diagnostic accuracy for septic shock and risk of 30-day all-cause mortality.
In contrast, albumin did not predict all-cause mortality.
The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying Therapies
Disease-modifying therapies in multiple sclerosis (MS) do not seem to adversely affect the course and outcome of COVID-19.
There is no need to withhold these treatments as this could lead to uncontrolled MS.
Patients on B-cell-depleting therapies should be closely monitored, though the risk of severity following infection is low.